HealthLinx's February's shareholder update page 11 states...........
Unit Sales estimates
– Year 1 2500 units
– Year 2 19,000 units
– Year 3 40,000 units
• These numbers are based on obtaining approx. 10% market share within the first three years of product release.
ovplex - ovarian cancer diagnostic test , page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.8¢ | 33.0¢ | $227.8K | 683.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 415951 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 449017 | 26 |
View Market Depth
| Last trade - 14.19pm 30/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |